212 related articles for article (PubMed ID: 1438381)
41. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.
Tarasenko TN; Cusmano-Ozog K; McGuire PJ
Mol Genet Metab; 2018 Sep; 125(1-2):144-152. PubMed ID: 30031688
[TBL] [Abstract][Full Text] [Related]
42. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
[TBL] [Abstract][Full Text] [Related]
43. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C
J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748
[TBL] [Abstract][Full Text] [Related]
44. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
[TBL] [Abstract][Full Text] [Related]
45. [Infant coma in the emergency department: 2 cases of MCAD deficiency].
Hoflack M; Caruba C; Pitelet G; Haas H; Mas JC; Paquis V; Berard E
Arch Pediatr; 2010 Jul; 17(7):1074-7. PubMed ID: 20434892
[TBL] [Abstract][Full Text] [Related]
46. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies.
Nouws J; Te Brinke H; Nijtmans LG; Houten SM
Hum Mol Genet; 2014 Mar; 23(5):1311-9. PubMed ID: 24158852
[TBL] [Abstract][Full Text] [Related]
47. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
[TBL] [Abstract][Full Text] [Related]
48. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency.
Schwenk WF; Hale DE; Haymond MW
Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828
[TBL] [Abstract][Full Text] [Related]
49. Plasma free fatty acids in mitochondrial fatty acid oxidation defects.
Martínez G; Jiménez-Sánchez G; Divry P; Vianey-Saban C; Riudor E; Rodés M; Briones P; Ribes A
Clin Chim Acta; 1997 Nov; 267(2):143-54. PubMed ID: 9469249
[TBL] [Abstract][Full Text] [Related]
50. Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings.
Catzeflis C; Bachmann C; Hale DE; Coates PM; Wiesmann U; Colombo JP; Joris F; Délèze G
Eur J Pediatr; 1990 May; 149(8):577-81. PubMed ID: 2347356
[TBL] [Abstract][Full Text] [Related]
51. Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.
van Eunen K; Volker-Touw CM; Gerding A; Bleeker A; Wolters JC; van Rijt WJ; Martines AM; Niezen-Koning KE; Heiner RM; Permentier H; Groen AK; Reijngoud DJ; Derks TG; Bakker BM
BMC Biol; 2016 Dec; 14(1):107. PubMed ID: 27927213
[TBL] [Abstract][Full Text] [Related]
52. Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse.
van Vlies N; Tian L; Overmars H; Bootsma AH; Kulik W; Wanders RJ; Wood PA; Vaz FM
Biochem J; 2005 Apr; 387(Pt 1):185-93. PubMed ID: 15535801
[TBL] [Abstract][Full Text] [Related]
53. Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid beta-oxidation defects: phenotype/metabolite correlations.
Giak Sim K; Carpenter K; Hammond J; Christodoulou J; Wilcken B
Mol Genet Metab; 2002 Aug; 76(4):327-34. PubMed ID: 12208138
[TBL] [Abstract][Full Text] [Related]
54. Quantitative acylcarnitine profiling in peripheral blood mononuclear cells using in vitro loading with palmitic and 2-oxoadipic acids: biochemical confirmation of fatty acid oxidation and organic acid disorders.
Schulze-Bergkamen A; Okun JG; Spiekerkötter U; Lindner M; Haas D; Kohlmüller D; Mayatepek E; Schulze-Bergkamen H; Greenberg CR; Zschocke J; Hoffmann GF; Kölker S
Pediatr Res; 2005 Nov; 58(5):873-80. PubMed ID: 16183823
[TBL] [Abstract][Full Text] [Related]
55. Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts.
Bertrand C; Largillière C; Zabot MT; Mathieu M; Vianey-Saban C
Biochim Biophys Acta; 1993 Jan; 1180(3):327-9. PubMed ID: 8422439
[TBL] [Abstract][Full Text] [Related]
56. Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation.
McCoin CS; Piccolo BD; Knotts TA; Matern D; Vockley J; Gillingham MB; Adams SH
J Inherit Metab Dis; 2016 May; 39(3):399-408. PubMed ID: 26907176
[TBL] [Abstract][Full Text] [Related]
57. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.
Millington DS; Terada N; Chace DH; Chen YT; Ding JH; Kodo N; Roe CR
Prog Clin Biol Res; 1992; 375():339-54. PubMed ID: 1438380
[No Abstract] [Full Text] [Related]
58. Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy.
Mendez-Figueroa H; Shchelochkov OA; Shaibani A; Aagaard-Tillery K; Shinawi MS
J Perinatol; 2010 Aug; 30(8):558-62. PubMed ID: 20668464
[TBL] [Abstract][Full Text] [Related]
59. Investigation of beta-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry.
Nada MA; Chace DH; Sprecher H; Roe CR
Biochem Mol Med; 1995 Feb; 54(1):59-66. PubMed ID: 7551818
[TBL] [Abstract][Full Text] [Related]
60. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
